Gary Tian
DEPARTMENT OF APPLIED FINANCE AND ACTUARIAL STUDIES
Macquarie University
Australia
Biography
Gary is Professor of Finance in the School of Business and Economics, Macquarie University. He was a former Professor and Directors of HDR and Research in the Department of Finance and founding Director of the Centre of Business Research in China at Deakin Business School. He was also former Professor of Finance and Director of Chinese Commerce Research Centre at Wollongong University. He has held various visiting professorships in universities in China such as Shanghai University of Finance and Economics, Southwestern University of Finance and Economics, and Jinan University. Professor Tian has supervised more than dozen PhD students. His research interests focus on corporate finance including political connections, CEO compensation, bank lending and informal finance, investment efficiency and mergers and acquisitions and audit opinions and auditor choice. Gary has published in leading finance journals such as the Journal of Corporate Finance (2011, 2012, 2013, 2015) and Journal of Banking and Finance (2015 and two papers in press). Last year, as one of CIs, he secured the only ARC Discovery Grant in the field of finance (2015-2017). He won a Best Paper Awards from the Financial Management Association in 2011 and Pacific Basin Finance Journal in 2015 and Emerald Citations of Excellence Award for 2015 for his authored paper published in Journal of Corporate Finance in 2012.
Research Interest
Political connections, uncertainty and corruption CEO compensation/turnover State ownership and family control Audit opinions and auditor choice Bank loans and Trade credit Investment efficiency and Mergers and Acquisitions Chinese capital markets
Publications
-
Tian GG, Wan GH, Guo M. Market efficiency and the returns to simple technical trading rules: new evidence from US equity market and Chinese equity markets. Asia-Pacific Financial Markets. 2002 Sep 1;9(3):241-58.
-
Sequist LV, Cassier P, Varga A, Tabernero J, Schellens JH, Delord JP, LoRusso P, Camidge DR, Medina MH, Schuler M, Campone M. Abstract CT326: Phase I study of BGJ398, a selective pan-FGFR inhibitor in genetically preselected advanced solid tumors.
-
Zeitun R, Tian GG. Capital structure and corporate performance: evidence from Jordan.